Dr. Kai Bindseil is head of Division Healthcare | Industry | Infrastructure at Berlin Partner for Business and Technology. Dr. Kai Uwe Bindseil studied chemistry at Georg August University in Göttingen and completed his doctoral thesis in bioorganic chemistry. After a post-doctoral fellowship at Ciba-Geigy AG in Basle, he moved to AnalytiCon AG in Berlin and Potsdam, where he was COO and responsible for drug discovery, marketing and international business development. In 2001, Dr. Bindseil became Director of the biotech platform BioTOP Berlin-Brandenburg, where he played a key role in building and shaping the new HealthCapital cluster. He supported the German and European biotechnology as member of the board of Gesundheitsstadt Berlin, spokesman of the working group of German bioregions and steering group member of Scanbalt and the Council of European BioRegions CEBR. He is responsible for the Inbound Acquisition activities of Berlin Partner and serves frequently as a jury member for various innovation and business competitions, including the Healthcare Innovations Bridge and the Berlin Business Plan Competition